Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people notice the earliest effects of weight loss injections within the first one to two weeks, though meaningful weight reduction typically builds over two to three months. In clinical trials of tirzepatide (Mounjaro), participants lost an average of around 20% of body weight over 72 weeks — a result that unfolded gradually, not overnight. These are prescription-only medicines; a prescriber assesses whether they're clinically suitable for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The first thing most people notice is not a number on the scales. It is the quiet shift in appetite, feeling full after less food, losing interest in a second helping, forgetting to snack. Both tirzepatide and semaglutide slow the rate at which food leaves the stomach and signal satiety to the brain, so this change can appear within days of the first injection.
The starting doses for both medicines are deliberately low. Tirzepatide (Mounjaro) begins at 2.5 mg; the first pen's job is to let your body adjust, not to deliver peak effect. Semaglutide (Wegovy) follows a similarly careful opening pattern. You may lose a small amount of weight in week one or two, but it is not the headline figure. Side effects (mainly nausea, fatigue, and some digestive changes) tend to peak during this adjustment phase and ease off for most people within a couple of weeks. The NHS medicines page for tirzepatide gives a clear overview of what to expect in the early weeks.
One practical detail: if you are taking your injection on a Monday morning and wondering whether anything is happening, something usually is, just not visibly yet. Give it time.
After the starter dose, your prescriber titrates upward, typically in four-week steps. This is where most people begin to see consistent, measurable weight loss. Clinical data from the SURMOUNT-1 trial (which enrolled thousands of adults with obesity) showed that weight reduction was broadly linear across the first six months, with the steepest relative loss occurring as doses moved through the mid-range.
How quickly the weight loss injection works for any individual depends on the dose they have reached, the calorie deficit they are maintaining alongside treatment, their starting weight, and factors like insulin sensitivity. Two people starting on the same day can look meaningfully different by week twelve. That is not a failure of the medicine; it reflects biology. Understanding how weight loss injections work mechanically can help set realistic expectations for this phase.
For many people, the two-month mark brings a useful sense of momentum. Clothes fit differently before the number on the scales feels dramatic. That is a real signal the treatment is working. If you want a broader sense of what other patients ask at this stage, our frequently asked questions covers the most common mid-treatment queries.
The clearest finding from the longer trials is that weight loss injections continue working well beyond the first month. In SURMOUNT-1, participants using the highest dose of tirzepatide had lost an average of around 20% of body weight by 72 weeks. The STEP 1 trial of semaglutide 2.4 mg showed roughly 15% average reduction over 68 weeks. Both figures come from peer-reviewed data published in the New England Journal of Medicine.
Critically, these are averages across thousands of participants. Some lost more, some less. The trials also required participants to make dietary and activity changes alongside medication, which matters: the injections reduce hunger significantly, but they work best when that reduced appetite is paired with nourishing, protein-adequate eating.
People sometimes worry that results plateau early. They can slow, particularly around the three-to-six-month window, but this often reflects the body temporarily stabilising rather than the medicine stopping. If weight loss stalls meaningfully at the highest tolerated dose after six months, your prescriber will review the situation. Results do not arrive in a straight line; sustained downward trend across the year is the right way to measure progress. You can also read about how long weight loss injections take to work for a deeper look at longer timelines.
The pace of weight loss injections varies between people for reasons that are largely biological. Starting BMI plays a role: someone starting at BMI 42 may lose a greater absolute number of kilograms in the same period than someone at BMI 30, even if the percentage is similar. Metabolic rate, gut motility, and how consistently food intake adjusts alongside appetite reduction all contribute.
The medicine itself matters too. Tirzepatide acts on two gut-hormone receptors (GIP and GLP-1), while semaglutide targets one. Head-to-head evidence from the SURMOUNT-5 trial suggests tirzepatide produces greater average weight reduction than semaglutide 2.4 mg over the same period, though individual results always vary. A comparison of the two options is covered in detail on the weight loss injection overview.
Lifestyle factors are not a moral question. They are a practical one: the appetite-suppressing effect of these medicines creates a window to eat differently, and using that window (more protein, steady hydration, some movement) accelerates results. Our prescribers discuss this as part of the clinical review, not as an afterthought. If you are based locally and want to explore treatment nearby, our page on weight loss injections in Southampton explains how to get started with a prescriber in the area. For those wondering whether faster results are achievable, our guide to quick weight loss injections sets out what the evidence realistically supports. If you are weighing up the practical and financial side of starting, the cost of weight loss injections page explains what a legitimate private prescription typically includes. When you are ready to see whether treatment is appropriate for you, you can check your eligibility with our prescribers at no charge.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.